| abstract |
The present invention provides a composition comprising a platelet aggregation inhibitor, for example, cilostazole or a salt or derivative thereof, which may be used in the treatment or in the prevention of ischemic symptoms. The invention provides a composition comprising nanoparticles comprising the platelet aggregation inhibitor and at least one surface stabilizer. The nanoparticles have an effective average particle size of less than about 2000 nm. The invention also provides a composition which supplies a platelet aggregation inhibitor or nanoparticles containing it, in a pulsed or continuous manner. |